SARS-COV-2 Vaccines and Neurodegenerative Disease

Since December 2020, when several novel unprecedented vaccines against SARS-CoV-2 began to be approved for emergency use, there has been a worldwide effort to get these vaccines into the arms of as many people as possible as fast as possible. These vaccines have been developed “at warp speed,” given the urgency of the situation with the COVID-19 pandemic. Most governments have embraced the notion that these vaccines are the only path towards resolution of this pandemic, which is crippling the economies of many countries.

Well researched article by Stephanie Seneff, a senior research scientist at MIT, where she has had continuous affiliation for more than five decades. Reaffirming that despite the risks, experimental vaccines have been pushed as the ONLY solution from day one.